標(biāo)題: Titlebook: Clinical Trials in Osteoporosis; Derek Pearson (Clinical Director),Colin G. Miller Book 20021st edition Springer-Verlag London 2002 Clini [打印本頁] 作者: Boldfaced 時間: 2025-3-21 19:50
書目名稱Clinical Trials in Osteoporosis影響因子(影響力)
書目名稱Clinical Trials in Osteoporosis影響因子(影響力)學(xué)科排名
書目名稱Clinical Trials in Osteoporosis網(wǎng)絡(luò)公開度
書目名稱Clinical Trials in Osteoporosis網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinical Trials in Osteoporosis被引頻次
書目名稱Clinical Trials in Osteoporosis被引頻次學(xué)科排名
書目名稱Clinical Trials in Osteoporosis年度引用
書目名稱Clinical Trials in Osteoporosis年度引用學(xué)科排名
書目名稱Clinical Trials in Osteoporosis讀者反饋
書目名稱Clinical Trials in Osteoporosis讀者反饋學(xué)科排名
作者: 意見一致 時間: 2025-3-21 22:55
Conclusions and Future Actions,y the densitometer technologist who will be responsible for ensuring subject data is adequately acquired, principal investigators and study monitors have a role in ensuring that the technologist is adequately prepared and is included as a member of the clinical trial team. The preparation will include both relevant training and trial documentation作者: GRAVE 時間: 2025-3-22 04:26 作者: 取消 時間: 2025-3-22 07:43 作者: 閑逛 時間: 2025-3-22 10:40 作者: 碌碌之人 時間: 2025-3-22 16:39
https://doi.org/10.1007/978-3-642-54353-1 the International Committee for Harmonization (ICH) and adopted by the Food and Drug Administration (FDA) for the USA. and the Committee for Proprietary Medicinal Products (CPMP) within Europe.. These cover issues that researchers must consider, such as:作者: 碌碌之人 時間: 2025-3-22 17:06
Satellite Tracking and ObservationModels, the particular extras and details that have to be evaluated, and this chapter provides an overview of these items. The sponsor needs to be aware of these items in a timely manner — all too often the novice will overlook an important detail until it becomes a critical issue. This chapter will help ensure these kinds of errors are avoided.作者: Ergots 時間: 2025-3-22 23:11
PSI Subsidence Monitoring in Groningen,ical area in its infancy, we can therefore expect a significant number of changes in the coming years, as the understanding of bone physiology becomes more comprehensive and the genetic factors leading to increased risk factors become known.作者: 出血 時間: 2025-3-23 02:04
Introductiont is understood by those working in it, but currently has no definition that is agreeable across the medical and scientific community and a poorly understood etiology. It is within this framework that the pharmaceutical industry is trying to develop new treatments for the so-called “silent epidemic”.作者: harpsichord 時間: 2025-3-23 07:23
Ethical Considerations the International Committee for Harmonization (ICH) and adopted by the Food and Drug Administration (FDA) for the USA. and the Committee for Proprietary Medicinal Products (CPMP) within Europe.. These cover issues that researchers must consider, such as:作者: subordinate 時間: 2025-3-23 11:00 作者: cumber 時間: 2025-3-23 14:48
Future Therapies and Clinical Trialsical area in its infancy, we can therefore expect a significant number of changes in the coming years, as the understanding of bone physiology becomes more comprehensive and the genetic factors leading to increased risk factors become known.作者: Irrepressible 時間: 2025-3-23 19:05 作者: GIST 時間: 2025-3-24 01:00
Oliver Montenbruck,Eberhard Gillthat there are many qualified sites able and willing to do this project should your commitment falter. You can congratulate yourself that you have been chosen to participate, but the site must be organized to get to work on the project quickly!作者: 詞匯記憶方法 時間: 2025-3-24 04:49 作者: 玩忽職守 時間: 2025-3-24 07:43 作者: 在前面 時間: 2025-3-24 10:40 作者: Axillary 時間: 2025-3-24 17:47 作者: foodstuff 時間: 2025-3-24 22:44
Data Analysis and Presentation: Writing a Paper for Publicationy to be included in a meta-analysis and demonstrate the effectiveness of your intervention in the treatment of osteoporosis. There are, unfortunately, a number of limitations that are common when writing up trials that lead to bias and the exclusion of studies from subsequent meta-analysis. These include:.作者: NADIR 時間: 2025-3-24 23:52 作者: 使害怕 時間: 2025-3-25 06:58 作者: 推遲 時間: 2025-3-25 07:56 作者: Agronomy 時間: 2025-3-25 12:22 作者: Palpate 時間: 2025-3-25 16:26
Satellite Precipitation Measurementpausal osteoporosis. Future possible developments, such as intravenous therapy and anabolic agents, such as parathyroid hormone are examined. Finally an individual approach to the choice of therapy is presented to stimulate debate as to a treatment schema.作者: badinage 時間: 2025-3-25 22:27 作者: 變量 時間: 2025-3-26 03:52 作者: 含沙射影 時間: 2025-3-26 04:50 作者: 遺傳 時間: 2025-3-26 09:41
Biochemical Markers of Bone Turnoverlimits scanning to 6-monthly intervals, so that observed changes are certain to be due to bone loss and not imprecision. The skilled nature of these techniques combined with the need for special equipment, and in the case of DXA exposure to ionizing radiation, has fueled the search for useful and re作者: 懦夫 時間: 2025-3-26 14:47 作者: BOOST 時間: 2025-3-26 19:27 作者: 儲備 時間: 2025-3-26 22:44 作者: organism 時間: 2025-3-27 03:27
Satellite Tracking and ObservationModels, are discussed in other books and are not the remit of this book. However, because of the nature of this therapeutic area, it is important to consider the particular extras and details that have to be evaluated, and this chapter provides an overview of these items. The sponsor needs to be aware of t作者: 藐視 時間: 2025-3-27 07:59
Oliver Montenbruck,Eberhard Gille sponsor has made an assessment of the patient population and facilities available. It is now up to the investigator, site administrator and staff to prove the sponsor made the right decision in placing the study at their site. Since delays in study start-up can cause a sponsor to lose millions of 作者: CAND 時間: 2025-3-27 10:55
Conclusions and Future Actions,ol procedures, it also encompasses adequate subject preparation, technologist preparation, observance of rigorous scanning and analysis protocols, and the use of regular, organized data shipments to DXA quality assurance centers. All members of the research team should regard these aspects as necess作者: Pepsin 時間: 2025-3-27 13:44 作者: 高度 時間: 2025-3-27 18:39 作者: 逃避系列單詞 時間: 2025-3-28 01:22 作者: 貧窮地活 時間: 2025-3-28 04:42
Error and Uncertainty Characterizationed to that of the normal population. It would be free of side effects and sufficiently inexpensive for widespread use. Its beneficial effects on bone would persist for a significant time once therapy was withdrawn, opening the way to intermittent courses of treatment. It should be effective when giv作者: 使無效 時間: 2025-3-28 07:43 作者: Graduated 時間: 2025-3-28 10:32
Remote Sensing and Digital Image Processingsh BMD at a particular time. Using serial DXA measurements it is possible to measure a change in BMD over a set period of time. It is presumed that these measured changes in BMD are due to alterations in bone turnover, but they are not direct measurements of bone turnover. Furthermore, DXA scans and作者: GUMP 時間: 2025-3-28 17:43
PSI Subsidence Monitoring in Groningen,nce the late 1980s and early 1990s that we have had the instruments available to us for the diagnosis and then treatment of this disease. Like any medical area in its infancy, we can therefore expect a significant number of changes in the coming years, as the understanding of bone physiology becomes作者: 藝術(shù) 時間: 2025-3-28 21:52 作者: palpitate 時間: 2025-3-29 00:33
https://doi.org/10.1007/978-3-642-54353-1Before initiating a clinical trial the sponsor must be assured that the equipment and techniques used can adequately answer the research question. In multicenter trials each center may have instruments from different manufacturers, compounding the issues involved in initiating the trial. The investigator needs to be assured that:作者: 密切關(guān)系 時間: 2025-3-29 03:58
Standardization and Pre-trial Quality ControlBefore initiating a clinical trial the sponsor must be assured that the equipment and techniques used can adequately answer the research question. In multicenter trials each center may have instruments from different manufacturers, compounding the issues involved in initiating the trial. The investigator needs to be assured that:作者: 減弱不好 時間: 2025-3-29 09:44
Satellite Network Robust QoS-aware Routinghere has not been a clear hypothesis, endpoints are inappropriate and the study design inadequate, then it is unlikely that the outcome of the study will be used to contribute to the process of regulatory approval, or form part of a meta-analysis. It is important to get the design right from the start. The time taken will be well worth it.作者: 茁壯成長 時間: 2025-3-29 12:36
Derek Pearson (Clinical Director),Colin G. Miller Specifically addresses the issue of clinical trials in osteoporosis (no book on the subject is in the Library of Congress Catalog).Combines a number of issues that have been brought together for the f作者: 苦笑 時間: 2025-3-29 17:53
http://image.papertrans.cn/c/image/228264.jpg作者: Malleable 時間: 2025-3-29 23:10
https://doi.org/10.1007/978-1-4471-3710-8Clinical Trials; Instrument; Methodology; Study; bone; clinical trial; drug; osteoporosis作者: 喃喃而言 時間: 2025-3-30 01:39
Springer-Verlag London 2002作者: cornucopia 時間: 2025-3-30 07:44 作者: saturated-fat 時間: 2025-3-30 11:44
Study Design and Endpointshere has not been a clear hypothesis, endpoints are inappropriate and the study design inadequate, then it is unlikely that the outcome of the study will be used to contribute to the process of regulatory approval, or form part of a meta-analysis. It is important to get the design right from the sta作者: Accede 時間: 2025-3-30 14:03
Ethical Considerations the declaration of Helsinki, Edinburgh Amendment 2000.. This has been enshrined in Good Clinical Practice (GCP) guidelines that have been produced by the International Committee for Harmonization (ICH) and adopted by the Food and Drug Administration (FDA) for the USA. and the Committee for Propriet作者: Albinism 時間: 2025-3-30 19:02 作者: 使成核 時間: 2025-3-30 22:32
Local Site Organizatione sponsor has made an assessment of the patient population and facilities available. It is now up to the investigator, site administrator and staff to prove the sponsor made the right decision in placing the study at their site. Since delays in study start-up can cause a sponsor to lose millions of
